Verastem VSTM
NASDAQ VSTM
$8.05 +0.13 (+1.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

Verastem (VSTM) Short term Debt (2018 - 2024)

Updated

Verastem (VSTM) posted Short term Debt of $9.87 million for Q3 2024, up 100.4% from the prior quarter.

Analysis

Verastem (VSTM) Short term Debt (2018 - 2024) Analysis & Trends

At the end of FY2018, Verastem's Short term Debt came in at $5.72 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Verastem 716.62 Mn 73.25 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 9.87 Mn
Jun 30, 2024 4.93 Mn
Sep 30, 2020 9.30 Mn
Jun 30, 2020 4.59 Mn
Dec 31, 2018 5.72 Mn
Sep 30, 2018 3.53 Mn
Jun 30, 2018 1.38 Mn
API Access

Verastem Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=VSTM&period=max&api_key=YOUR_API_KEY